In the journal The Lancet, DZIF researchers from the Research Center Borstel and their colleagues from England and South Africa make the case for optimising tuberculosis drug development. They
Drugs against malaria, tuberculosis, HIV and other infectious diseases are still urgently needed in poorer countries. According to World Health Organisation (WHO) estimates, almost 430,000 people died
Hopes for tuberculosis treatment have been raised by an international study in which DZIF scientists from the Research Center Borstel were also involved. Resistance to pyrazinamide und
An international team of scientists has had unexpected success in treating tuberculosis with a ß-lactam antibiotic that is approved for other indications. DZIF scientists from the Research Center
PanACEA, the Pan-African Consortium for the Evaluation of Antituberculosis Antibiotics, presented the results of its most recent phase IIb study. The most exciting finding from the study is that high
